Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12258393 | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha | Matthew Germinaro, Jacqueline Perrigoue, Marion Vetter | 2025-03-25 |
| 11780911 | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha | Matthew Germinaro, Jacqueline Perrigoue | 2023-10-10 |
| 11654142 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2023-05-23 |
| 11439629 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2022-09-13 |
| 11311532 | High dosage valbenazine formulation and compositions, methods, and kits related thereto | Richard A. Moore, Gregory A. McClelland | 2022-04-26 |
| 11040029 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2021-06-22 |
| 11026931 | Methods for the administration of certain VMAT2 inhibitors | Grace S. Liang, Dao Tuyet Thai-Cuarto | 2021-06-08 |
| 10993941 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2021-05-04 |
| 10961307 | Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody | Jewel Johanns, Katherine Li, Colleen Marano, Richard Strauss, Hongyan Zhang +2 more | 2021-03-30 |
| 10952997 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2021-03-23 |
| 10912771 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2021-02-09 |
| 10874648 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2020-12-29 |
| 10857137 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2020-12-08 |
| 10857148 | Methods for the administration of certain VMAT2 inhibitors | Haig P. Bozigian | 2020-12-08 |
| 10577414 | Use of reslizumab to treat moderate to severe eosinophilic asthma | James Zangrilli, Tushar Shah, Guy Brusselle | 2020-03-03 |
| 9815894 | Use of reslizumab to treat moderate to severe eosinophilic asthma | James Zangrilli, Tushar Shah | 2017-11-14 |